It’s an cannabinoid class chemical
Other name: ADB-CHMINACA
IUPAC name: N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide
CAS number: 1185887-13-1
Purity: 99,4% min
Appearance: white powder
ADB-CHMINACA (also known as MAB-CHMINACA) is an indazole-based synthetic cannabinoid. It is a potent agonist of the CB1 receptor with a binding affinity of Ki = 0.289 nM and was originally developed by Pfizer in 2009 as an analgesic medication. It was identified in cannabinoid blends in Japan in early 2015
This product is intended for research and forensic applications.